TY  - GEN
AU  - Galanis,Evanthia
AU  - Hartmann,Lynn C
AU  - Cliby,William A
AU  - Long,Harry J
AU  - Peethambaram,Prema P
AU  - Barrette,Brigitte A
AU  - Kaur,Judith S
AU  - Haluska,Paul J
AU  - Aderca,Ileana
AU  - Zollman,Paula J
AU  - Sloan,Jeff A
AU  - Keeney,Gary
AU  - Atherton,Pamela J
AU  - Podratz,Karl C
AU  - Dowdy,Sean C
AU  - Stanhope,C Robert
AU  - Wilson,Timothy O
AU  - Federspiel,Mark J
AU  - Peng,Kah-Whye
AU  - Russell,Stephen J
TI  - Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer
SN  - 1538-7445
PY  - 2010///0309
KW  - Abdominal Pain
KW  - etiology
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Animals
KW  - Carcinoembryonic Antigen
KW  - genetics
KW  - Chlorocebus aethiops
KW  - Fatigue
KW  - Female
KW  - Fever
KW  - Humans
KW  - Injections, Intraperitoneal
KW  - Measles virus
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Oncolytic Virotherapy
KW  - adverse effects
KW  - Oncolytic Viruses
KW  - Ovarian Neoplasms
KW  - pathology
KW  - Recombinant Fusion Proteins
KW  - administration & dosage
KW  - Treatment Outcome
KW  - Vero Cells
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/0008-5472.CAN-09-2762
ER  -